Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn

Table of Contents

August 01, 2017; Volume 92,Issue 2

Articles

  • You have access
    α2 Subunit–Containing GABAA Receptor Subtypes Are Upregulated and Contribute to Alcohol-Induced Functional Plasticity in the Rat Hippocampus
    A. Kerstin Lindemeyer, Yi Shen, Ferin Yazdani, Xuesi M. Shao, Igor Spigelman, Daryl L. Davies, Richard W. Olsen and Jing Liang
    Molecular Pharmacology August 2017, 92 (2) 101-112; DOI: https://doi.org/10.1124/mol.116.107797
  • You have access
    Alterations of Histone Modifications Contribute to Pregnane X Receptor-Mediated Induction of CYP3A4 by Rifampicin
    Liang Yan, Yiting Wang, Jingyang Liu, Yali Nie, Xiao-bo Zhong, Quancheng Kan and Lirong Zhang
    Molecular Pharmacology August 2017, 92 (2) 113-123; DOI: https://doi.org/10.1124/mol.117.108225
  • Open Access
    Direct Binding of the Corrector VX-809 to Human CFTR NBD1: Evidence of an Allosteric Coupling between the Binding Site and the NBD1:CL4 Interface
    Rhea P. Hudson, Jennifer E. Dawson, P. Andrew Chong, Zhengrong Yang, Linda Millen, Philip J. Thomas, Christie G. Brouillette and Julie D. Forman-Kay
    Molecular Pharmacology August 2017, 92 (2) 124-135; DOI: https://doi.org/10.1124/mol.117.108373
  • You have access
    C-X-C Motif Chemokine Receptor 3 Splice Variants Differentially Activate Beta-Arrestins to Regulate Downstream Signaling Pathways
    Jeffrey S. Smith, Priya Alagesan, Nimit K. Desai, Thomas F. Pack, Jiao-Hui Wu, Asuka Inoue, Neil J. Freedman and Sudarshan Rajagopal
    Molecular Pharmacology August 2017, 92 (2) 136-150; DOI: https://doi.org/10.1124/mol.117.108522
  • You have access
    Identification of AICP as a GluN2C-Selective N-Methyl-d-Aspartate Receptor Superagonist at the GluN1 Glycine Site
    Maja Jessen, Kristen Frederiksen, Feng Yi, Rasmus P. Clausen, Kasper B. Hansen, Hans Bräuner-Osborne, Paul Kilburn and Anders Damholt
    Molecular Pharmacology August 2017, 92 (2) 151-161; DOI: https://doi.org/10.1124/mol.117.108944
  • You have access
    β-Arrestin-Mediated Regulation of the Human Ether-a-go-go-Related Gene Potassium Channel
    Matthew G. Sangoi, Shawn M. Lamothe, Jun Guo, Tonghua Yang, Wentao Li, Ellen G. Avery, John T. Fisher and Shetuan Zhang
    Molecular Pharmacology August 2017, 92 (2) 162-174; DOI: https://doi.org/10.1124/mol.116.108035
  • You have access
    TCL1A Single-Nucleotide Polymorphisms and Estrogen-Mediated Toll-Like Receptor-MYD88–Dependent Nuclear Factor-κB Activation: Single-Nucleotide Polymorphism– and Selective Estrogen Receptor Modulator–Dependent Modification of Inflammation and Immune Response
    Ming-Fen Ho, James N. Ingle, Tim Bongartz, Krishna R. Kalari, Paul E. Goss, Lois E. Shepherd, Taisei Mushiroda, Michiaki Kubo, Liewei Wang and Richard M. Weinshilboum
    Molecular Pharmacology August 2017, 92 (2) 175-184; DOI: https://doi.org/10.1124/mol.117.108340
Back to top
PreviousNext

In this issue

Molecular Pharmacology: 92 (2)
Molecular Pharmacology
Vol. 92, Issue 2
1 Aug 2017
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts

Jump to

  • Articles
  • Most Cited
  • Most Read
Loading
  • SB-431542 Is a Potent and Specific Inhibitor of Transforming Growth Factor-β Superfamily Type I Activin Receptor-Like Kinase (ALK) Receptors ALK4, ALK5, and ALK7
  • The G-Protein-Coupled Receptors in the Human Genome Form Five Main Families. Phylogenetic Analysis, Paralogon Groups, and Fingerprints
  • Pharmacological Properties of Y-27632, a Specific Inhibitor of Rho-Associated Kinases
  • Pharmacological characterization of five cloned voltage-gated K+ channels, types Kv1.1, 1.2, 1.3, 1.5, and 3.1, stably expressed in mammalian cell lines.
  • The Orphan Human Pregnane X Receptor Mediates the Transcriptional Activation of CYP3A4 by Rifampicin through a Distal Enhancer Module
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics